Imaging manifestations of progressive multifocal leukoencephalopathy

R Shah1, A K Bag, P R Chapman

  • 1Division of Neuroradiology, Department of Diagnostic Radiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Clinical Radiology
|May 11, 2010
PubMed

Insights

Progressive multifocal leukoencephalopathy (PML) is a brain disease diagnosed using imaging and JC virus PCR. This review covers imaging techniques for diagnosing, monitoring, and predicting outcomes of PML.

Area of Science:

  • Neuroimaging
  • Infectious Diseases
  • Neurology

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a rare, severe demyelinating disease.
  • PML results from the reactivation of JC virus in immunocompromised individuals.
  • Diagnosis typically involves imaging and cerebrospinal fluid analysis.

Purpose of the Study:

  • To comprehensively review the imaging features of PML.
  • To detail the role of various imaging modalities in PML diagnosis and management.
  • To discuss imaging's utility in patient follow-up and prognosis.

Main Methods:

  • Review of imaging manifestations of PML.
  • Inclusion of computed tomography (CT), magnetic resonance imaging (MRI), diffusion-weighted imaging (DWI), diffusion tensor imaging (DTI), MR spectroscopy, single photon-emission computed tomography (SPECT), and positron-emission tomography (PET).

Main Results:

  • Detailed description of PML's appearance across multiple imaging techniques.
  • Highlighting specific imaging findings indicative of PML.
  • Emphasis on the diagnostic and prognostic value of advanced imaging.

Conclusions:

  • Imaging plays a critical role in the early diagnosis and characterization of PML.
  • Advanced neuroimaging techniques aid in assessing disease extent and guiding treatment.
  • Imaging is essential for monitoring treatment response and predicting patient outcomes in PML.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...